Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Author: John C. Goodman

Friday Links

Posted on February 9, 2024February 8, 2024 by John C. Goodman
  • “You can very clearly halve your children’s risk of schizophrenia through polygenic selection, which costs only a few hundred dollars if you’re already doing IVF…. In a decade or two you can probably eliminate the risk entirely.”
  • Roughly 90 percent of Americans are effectively blocked from opening an HSA.
  • How to create HSAs in the Obamacare Exchanges. (National Review)
  • Americans who trust the government to do the right thing most of the time: 10%  Elites: 79%  Super Elites: 89%. Maybe that’s because the elites run the government.
  • What the future holds for weight loss drugs. (Bloomberg)
  • Have economists oversold the idea of “moral hazard”?
+

Thursday Links

Posted on February 8, 2024February 7, 2024 by John C. Goodman
  • Prescription drug pricing: Most cost-effectiveness analyses exclude probable end-of-patent, life cycle pricing – and set the initial price too low.
  • Private approaches may be the best answer to public health problems.
  • Rep Michael Burgess on why the CBO needs to consider the long-term benefits of preventive medicine.
  • Looks like there are more deaths by fire than by ice. But there are still more deaths by cold than by warming.
+

Wednesday Links

Posted on February 7, 2024February 7, 2024 by John C. Goodman
  • How to get more kidney transplants without creating a market for kidneys.
  • If new drugs can make it in America, they are developed. If they can’t, they aren’t.
  • “A box of fruit or vegetables says ‘Produced in California’ or ‘Origin: Mexico,’ but you have no idea where a container of generic Tylenol  came from or whether you can feel confident in the product.”
  • Standing in the way of a cure for Parkinson’s disease: the FDA bureaucracy.
+

Is Kamala Harris Calling for the Abolition of the FDA?

Posted on February 6, 2024 by John C. Goodman

“In America, freedom is not to be given, not to be bestowed, but it is ours by right,” Harris said. “And that includes the freedom to make decisions about one’s own body, and not have the government telling people what to do.”

Savannah Morning News

+
  • Previous
  • 1
  • …
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • …
  • 368
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom